Evidence map›Paper›PMID 37111439›Full record

ReviewPathogens (Basel, Switzerland)2023

Human

Jed Burde, Evan M Bloch, Jill R Kelly, Peter J Krause

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Borrelia surface proteins: new horizons in Lyme disease diagnosis.Applied microbiology and biotechnology · 2025
    Review
  4. Infection and immunity · 2025
    Article
  5. Review
  6. Prevalence ofMicroorganisms · 2024
    Article
  7. Article
  8. Developing a Prospective Gestational Lyme Disease Study.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Detection of multiple tick-borne pathogens inCurrent research in parasitology & vector-borne diseases · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jed BurdeDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520, USA.
Evan M BlochDivision of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD 21217, USA.ORCID 0000-0001-8181-9517
Jill R KellyDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06520, USA.
Peter J KrauseDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520, USA.ORCID 0000-0003-3498-9454
Yale University · USJohns Hopkins University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Borrelia miyamotoiemerging infectionepidemiologyhumanrelapsing feverticks

Identifiers

PMID37111439
PMCPMC10145171
OpenAlexW4362580394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.